| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | SVP, COO &CFO | Director +2 more
3 companies
Labrucherie Gil M is a SVP, COO &CFO at NEKTAR THERAPEUTICS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $22.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 45,001 | $15.87 | $714,165.87 | -89.6% | |
| Nov 11, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 45,000 | $13.52 | $608,400.00 | -90.5% | |
| Oct 6, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 45,000 | $10.99 | $494,550.00 | -90.5% | |
| Sep 23, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 44,999 | $13.04 | $586,786.96 | -90.5% | |
| Aug 13, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 33,333 | $10.89 | $362,996.37 | -87.5% | |
| Jul 14, 2015 | NKTR Nektar Therapeutics | SVP &General Counsel | Sale+OE | 33,334 | $11.78 | $392,674.52 | -88.7% |